Gastroesophageal Junction (GEJ) Adenocarcinoma Clinical Trials

11 clinical trials for Gastroesophageal Junction (GEJ) Adenocarcinoma across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma — RECRUITING · PHASE2
• A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer — RECRUITING · PHASE3
• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer — RECRUITING · PHASE1
• Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma — RECRUITING · PHASE1
• First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 — RECRUITING · PHASE1
• An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE2
• Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma — NOT_YET_RECRUITING · PHASE2
• The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors — OTHER · PHASE1

Refine this search